Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps—Are We Comparing Apples With Oranges?
International Forum of Allergy & Rhinology · 2026
DOI: 10.1002/alr.70205 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Forum of Allergy & Rhinology, 2026. Verfasst von Marjolein Cornet und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Alrijne Hospital, Leiderdorp, Netherlands. Hauptthemen laut MEDLINE: Rhinosinusitis, Nasal Polyps, Biological Products, Sinusitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK, GlaxoSmithKline.
Abstract (Originalsprache)
Key Points In recent years, several biologics targeting Type 2 inflammation have been developed for treating chronic rhinosinusitis with nasal polyps (CRSwNP). These have been studied in registrational randomized controlled trials (RCTs), which vary in their patient populations, trial design, endpoints, geography, timing, or data‐handling processes. While (in)direct treatment comparisons and meta‐analyses have been carried out to compare efficacy results from RCTs, often these fail to properly account for these between‐study differences. Here, we summarize the key between‐study differences that can influence trial outcomes and highlight the resulting challenges faced when comparing outcomes from different Phase III RCTs of biologics in CRSwNP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Alrijne Hospital, Leiderdorp, Netherlands.
- Department of Otorhinolaryngology, Catholic University of Leuven, and Upper Airways Research Laboratory, University of Ghent, Ghent, Belgium.
- University of Montreal Hospital Center and Research Center Surgery, Université De Montréal, Montreal, Quebec, Canada.
- Department of Otorhinolaryngology, Düsseldorf University Hospital (UKD), Düsseldorf, Germany.
- Clinical Sciences, Respiratory, Immunology & Inflammation Research Unit, GSK, London, UK.
- Global Medical, Specialty Care, GSK, Wavre, Belgium.
ORCID-Profile: Martin Desrosiers, Martin Wagenmann
Förderung
- GSK
- GlaxoSmithKline
Zitieren
APA
Cornet, M., Hellings, P. W., Desrosiers, M., Wagenmann, M., Follows, R., Walrave, L., Jimenez, L. A., Tombs, L., Edwards, D., Howarth, P., & Han, J. K. (2026). Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps—Are We Comparing Apples With Oranges?. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.70205
Vancouver
Cornet M, Hellings PW, Desrosiers M, Wagenmann M, Follows R, Walrave L, et al. Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps—Are We Comparing Apples With Oranges?. International Forum of Allergy & Rhinology. 2026. doi:10.1002/alr.70205
BibTeX
@article{Cornet2026,
author = {Cornet, Marjolein and Hellings, Peter W and Desrosiers, Martin and Wagenmann, Martin and Follows, Richard and Walrave, Laura and Jimenez, Luz Adriana and Tombs, Lee and Edwards, Dawn and Howarth, Peter and Han, Joseph K},
title = {Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps—Are We Comparing Apples With Oranges?},
journal = {International Forum of Allergy & Rhinology},
year = {2026},
doi = {10.1002/alr.70205}
}
EUVIMED